Anzeige
Mehr »
Login
Freitag, 27.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Insider-Alarm: Warum Insider Millionen von Aktien dieses Goldwerts kaufen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
447 Leser
Artikel bewerten:
(2)

Statistics Report: Global Blood Testing Market Size & Share to Surpass USD 128.45 Billion by 2028, Predicts Zion Market Research | Industry Trends, Growth, Value, Segmentation Analysis & Forecast by ZMR

NEW YORK, Aug. 1, 2022 /PRNewswire/ -- As per Zion Market Research study, The global blood testing market size was worth around USD 80.50 billion in 2021 and is estimated to grow to about USD 128.45 billion by 2028, with a compound annual growth rate (CAGR) of approximately 8.10 percent over the forecast period.

Zion_Market_Research_Logo

Blood Testing Market: Overview

Blood tests are the most basic diagnostic method used to determine the malfunction of the human system. Regular blood tests are the easiest way to track your health. It is essential to have regular blood tests for good health and to make informed decisions about health in particular. Blood tests are also important to reduce the risk of various illnesses and related complications. Increased government and regulatory healthcare costs are expected to drive the market during the forecast period. Therefore, governments and key organizations constantly strive to encourage patients to undergo regular diagnostic tests. Furthermore, recent advances, the regulatory approval process, and a lack of awareness of the high cost of automated blood tests will hinder market growth over the next few years. Multinational healthcare institutions can help discover new technologies and raise awareness for eradicating & diagnosing common and chronic diseases. Solid external funding for clinical trials being conducted to develop new and innovative diagnostic tests is expected to boost the market. The introduction of constructive regulatory parameters to encourage POC tests is a major rendering driver on the market.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/blood-testing-market

Our Free Sample Report Includes:

  • 2022 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 266 + Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes an Updated List of tables & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Zion Market Research methodology

Key Industry Insights & Findings of the Blood Testing Market Reports:

  • As per the analysis shared by our research analyst, the Blood Testing Market is expected to grow annually at a CAGR of around 8.10 % (2022-2028).
  • Through the primary research, it was established that the Blood Testing Market was valued at approximately USD 80.50 billion in 2021 and is projected to reach roughly USD 128.45 billion by 2028.
  • Increasing the number of strategic initiatives taken by government agencies and market players to increase blood donations across the region is one of the factors expected to drive North America market growth.
  • New York Blood Center, American Red Cross, AABB, America's Blood Centers, Armed Services Blood Program, and Blood Centers of America, provide information on plasma collection and plasma delivery.
  • Asia Pacific region, the blood testing market is expected to show the fastest CAGR during the forecast period. The increasing prevalence of chronic diseases in developing countries such as India and China is a major driver of market growth.

Zion Market Research published the latest report titled "Blood Testing Market By Test Type (Lipid Panel Testing, Prostate-Specific Antigen, COVID-19, Complete blood count (CBC), BUN testing (Blood Urea Nitrogen), Glucose testing, A1C, Direct LDL, Cortisol, Creatinine, and Others tests), By End-user (Hospitals, Clinic, Diagnostic Centre, Research laboratories, and Others (Blood Banks)), By Method (Manual and Automated), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 - 2028." into their research database.

Industry Dynamics:

Blood Testing Market: Growth Drivers

  • Rising initiative of regulatory bodies and healthcare organizations in blood test help to drive the market.

Regulators such as the FDA, Medicare and Medicaid Service Center (CMS), and the Federal Trade Commission play an important role in regulating diagnostic tests. These agencies have taken the initiative to commercialize clinical laboratory improvement and modification compliant diagnostic tests that may help in the early detection of illness. The introduction of CLIA in the United States is expected to increase blood test used during the prediction period.

Blood Testing Market: Restraints

  • Stringent regulatory approval process will hinder the market growth.

Rigid regulatory approval strategies are likely to hamper the market growth in the coming years. In the U.S., the development of commercial trials is regulated by the U.S. Food and Drug Administration (U.S. FDA). The US FDA is responsible for approving the use of clinical tests. Lack of awareness of the development of new technologies and procedures related to blood tests will hamper the market over the forecast period.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/blood-testing-market

Global Blood Testing Market: Segmentation

  • The global blood testing market is segregated based on test type, end-use, method, and region.

By test type, the market is divided into lipid panel testing, prostate-specific, antigen, COVID-19, complete blood count (CBC), BUN testing (blood urea nitrogen), glucose testing, A1C, direct LDL, cortisol, creatinine, and other tests. Among these, the glucose testing segment dominates the market owing to technological advances in these glucose meters, etc. Wireless connectivity and Bluetooth capabilities further drive the market acceptance of these products. iHealth Smart, iHealth Align, Dario Health Smart Meter and Glooko are examples of smart blood glucose monitoring products.

By end user, the market is classified into hospitals, clinics, diagnostic centers, research laboratories, and others (blood banks). Over the forecast period, the research laboratories segment is expected to develop at the fastest rate. Laboratory tests of blood and blood products provided for infections are an important safety measure to protect patients and prevent the spread of serious infections. Factors such as increased blood donation & blood transfusion-related screening, increased awareness of blood transfusion-related infectious diseases, and increased incidence of infectious diseases are driving the growth of this segment.

By method, the market is classified into manual and automated. The automated segment dominates the market.

Get More Insight before Buying@: https://www.zionmarketresearch.com/inquiry/blood-testing-market

List of Key Players in Blood Testing Market:

  • Richard Wolf GmbH
  • WISAP Medical Technology
  • KARL STORZ GmbH & Co. KG
  • Stryker
  • Teleflex Inc.
  • Ethicon LLC
  • Centrel
  • OPTOMIC
  • Medgyn Products Inc.
  • Maxer Endoscopy
  • Vimex Sp. z o.o
  • Olympus Corporation
  • Henke-Sass Wolf.

Key questions answered in this report:

  • What are the growth rate forecast and market size for Blood Testing Market?
  • What are the key driving factors propelling the Blood Testing Market forward?
  • What are the most important companies in the Blood Testing Market Industry?
  • What segments does the Blood Testing Market cover?
  • How can I receive a free copy of the Blood Testing Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 80.50 Billion

Revenue forecast in 2028

USD 128.45 Billion

Growth Rate

CAGR of almost 8.10 % 2022-2028

Base Year

2020

Historic Years

2016 - 2021

Forecast Years

2022 - 2028

Segments Covered

By Product Type, By Application, And By End Use

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Richard Wolf GmbH, WISAP Medical Technology, KARL STORZ GmbH & Co. KG, Stryker, Teleflex Inc. Ethicon LLC, Centrel, OPTOMIC, Medgyn Products, Inc., Maxer Endoscopy, Vimex Sp. z o.o, Olympus Corporation, and Henke-Sass Wolf.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail of customized purchase options to meet your exact research needs.

https://www.zionmarketresearch.com/custom/3134

Free Brochure: https://www.zionmarketresearch.com/requestbrochure/blood-testing-market

Recent Developments

  • In February of 2022, Tasso, a manufacturer of portable blood collection devices, partnered with telemedicine company Vault Health to help perform diagnostic tests at home. Vault offers remote services such as COVID-19 testing, alcohol testing, and drug testing for businesses.
  • In March 2022, AXIM Biotechnologies, Inc, an international healthcare solutions company focused on the dry eye (DED), has changed the focus of COVID-19 rapid neutralizing antibody testing to "research use only.

Regional Dominance:

·Increasing strategies of key market players and government organizations likely to help North America dominate the global market.

Increasing the number of strategic initiatives taken by government agencies and market players to increase blood donations across the region is one of the factors expected to drive North America market growth. Blood centers across the country are stepping up efforts to collect blood from people who have recovered from their illnesses. Several organizations, such as the New York Blood Center, American Red Cross, AABB, America's Blood Centers, Armed Services Blood Program, and Blood Centers of America, provide information on plasma collection and plasma delivery. Increased blood donations are expected to further drive demand for testing products for pre-transplant and post-transplant procedures. In the Asia Pacific region, the blood testing market is expected to show the fastest CAGR during the forecast period. The increasing prevalence of chronic diseases in developing countries such as India and China is a major driver of market growth.

Global Blood Testing Market is segmented as follows:

Blood Testing Market: By Test Type Outlook (2022-2028)

  • Lipid Panel testing
  • Prostate-Specific Antigen
  • COVID-19
  • Complete blood count (CBC)
  • BUN testing (Blood Urea Nitrogen)
  • Glucose testing
  • A1C
  • Direct LDL
  • Cortisol
  • Creatinine
  • Others tests

Blood Testing Market: By End User Outlook (2022-2028)

  • Hospitals
  • Clinics
  • Diagnostic Centre
  • Research laboratories
  • Others (Blood Banks)

Blood Testing Market: By Method Outlook (2022-2028)

  • Manual
  • Automated

Blood Testing Market: By Region Outlook (2022-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release For Blood Testing Market: https://www.zionmarketresearch.com/news/global-blood-testing-market

Browse Other Related Research Reports from Zion Market Research

  • Blood Group Typing Market - Global Industry Analysis: The global blood group typing market size was worth USD 2,954.90 million in 2021 and is estimated to grow to USD 5,093.63 million by 2028, with a compound annual growth rate (CAGR) of approximately 9.50 percent over the forecast period.
  • Smart Hospitals Market - Global Industry Analysis: The global smart hospitals market size was worth USD 23.10 million in 2021 and is estimated to grow to USD 84.38 million by 2028, with a compound annual growth rate (CAGR) of approximately 24.10 percent over the forecast period.
  • Mineral Supplements Market - Global Industry Analysis: The global mineral supplements market size was worth USD 13.1 billion in 2021 and is estimated to grow to USD 14.8 billion by 2028, with a compound annual growth rate (CAGR) of approximately 2.10% over the forecast period.

Browse through Zion Market Research's coverage of the Global Healthcare Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.